drugset / Trial / NCT05892042

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

NCT05892042

Recruiting 320 enrolled Jilin University
RandomizedParallel-groupOpen-labelTreatment

Summary

Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction

Timeline

Start
2023-05-01
Primary completion
2026-09-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivaroxaban Other / unclassified 15 mg